Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Thomas M Ellis"'
Autor:
Brad C. Astor, Sandesh Parajuli, Joshua D. Mezrich, Didier A. Mandelbrot, Robert R. Redfield, Neetika Garg, Luis G. Hidalgo, Dixon B. Kaufman, Arjang Djamali, Thomas M. Ellis
Publikováno v:
American Journal of Transplantation. 20:3443-3450
Third-party vascular allografts (VAs) are an invaluable resource in kidney and pancreas transplantation when vascular reconstruction is needed and additional vessels from the organ donor are not available. We report the largest single-center experien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf9c2e093df5e9a3a319a13bd0b2049
https://doi.org/10.1111/ajt.16009
https://doi.org/10.1111/ajt.16009
Autor:
Matthew Inkman, Fiona Ruiz, Kay Jayachandran, Thomas M. Ellis, Yufeng Wu, Christopher A. Miller, Jin Zhang, Akinyemi I. Ojesina, Michael D. McLellan, Julie K. Schwarz
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports
Scientific Reports
Accurate HPV genotyping is crucial in facilitating epidemiology studies, vaccine trials, and HPV-related cancer research. Contemporary HPV genotyping assays only detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036717aaa910827039faee3c9a8a882a
http://link.springer.com/article/10.1038/s41598-020-71300-7
http://link.springer.com/article/10.1038/s41598-020-71300-7
Autor:
Weixiong Zhong, Neetika Garg, Sandesh Parajuli, Arjang Djamali, Fahad Aziz, Maha Mohamed, Brenda Muth, Didier A. Mandelbrot, Thomas M. Ellis
Publikováno v:
Clinical nephrology. 91(2)
Background Risk factors for graft loss in kidney transplant recipients with g3 lesions are poorly defined. Materials and methods We evaluated outcomes in 37 consecutive kidney transplant biopsies diagnosed with g3 glomerulitis based on Banff 2013 cri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb3a2dee627b252f288b255e7e4c316
https://pubmed.ncbi.nlm.nih.gov/30474594
https://pubmed.ncbi.nlm.nih.gov/30474594
Autor:
Thomas M. Ellis, Joseph R. Scalea, Robert R. Redfield, Maha Mohamed, Arjang Djamali, Nancy A. Wilson, Brenda Muth, Dixon B. Kaufman
Publikováno v:
Clinical Transplantation. 29:1090-1097
Background There is a paucity of data stratifying by age the incidence of antibody-mediated rejection (AMR) in kidney transplant patients. Methods We performed a retrospective study of all adult, renal transplant recipients at a single institution be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8ade2a811bca7937c1934ec78af61d
https://doi.org/10.1111/ctr.12632
https://doi.org/10.1111/ctr.12632
Publikováno v:
Transplantation. 99:1151-1155
BACKGROUND: Complement fixation by donor-specific HLA antibodies (DSA) is a primary mechanism for antibody-mediated damage of organ allografts. Using a recently developed kit that measures C1q binding to distinguish complement fixing and nonfixing an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20152d0adb20d0ef2637c18e90f30401
https://doi.org/10.1097/tp.0000000000000699
https://doi.org/10.1097/tp.0000000000000699
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 17(12)
There is limited information about the role of protocol kidney biopsies for de novo donor-specific antibodies (dnDSA) in kidney transplant recipients, especially in those with stable graft function. We initiated a routine posttransplant DSA monitorin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2bfb65d4094847fa64e125fea9cf83
https://pubmed.ncbi.nlm.nih.gov/28805293
https://pubmed.ncbi.nlm.nih.gov/28805293
Autor:
Dixon B. Kaufman, Thomas M. Ellis, Arthur J. Matas, Arjang Djamali, Weixiong Zhong, Millie Samaniego
Publikováno v:
American Journal of Transplantation
Advances in multimodal immunotherapy have significantly reduced acute rejection rates and substantially improved 1-year graft survival following renal transplantation. However, long-term (10-year) survival rates have stagnated over the past decade. R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f399e0df597878ad3f71af0c46728b
https://doi.org/10.1111/ajt.12589
https://doi.org/10.1111/ajt.12589
Autor:
Amy J. Powell, Rashmi Agni, Glen Leverson, Courtney M. Pigott, Alexandru I. Musat, Michael R. Lucey, Anthony M. D'Alessandro, Katelyn R. Richards, Thomas M. Ellis
Publikováno v:
Liver Transplantation. 19:1132-1141
The significance of preexisting donor-specific HLA antibodies (HLA-DSAs) for liver allograft function is unclear. Our previous studies have shown that humoral alloreactivity frequently accompanies acute cellular rejection (ACR). In the present study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8abb6eee988115f5e7b18580ad23aefe
https://doi.org/10.1002/lt.23707
https://doi.org/10.1002/lt.23707
Autor:
Kathleen Hopp, Bradley C. Pietz, David P. Bick, Thomas M. Ellis, Eduardo C. Lau, Jennifer J. Schiller
Publikováno v:
Human Immunology. 74:562-566
Identifying an HLA-matched sibling donor for hematopoietic stem cell transplantation (HSCT) is time-consuming and expensive, and often limited by reimbursement caps imposed by insurance providers. To improve the effectiveness and efficiency of screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe04f9a9d4d80884c8850e1e14e60703
https://doi.org/10.1016/j.humimm.2012.12.015
https://doi.org/10.1016/j.humimm.2012.12.015
Autor:
Karen M. Miller, Dixon B. Kaufman, Jose R. Torrealba, David P. Foley, R. Michael Hofmann, Joshua D. Mezrich, Arjang Djamali, Thomas M. Ellis, Luis A. Fernandez, Jon S. Odorico, Janet M. Bellingham, Vijay Vidyasagar, Tony M. D'Alessandro, John D. Pirsch, Brenda Muth, Maha Mohamed
Publikováno v:
Kidney international
In order to define the intensity of immunosuppression, we examined risk factors for acute rejection in desensitization protocols that use baseline donor specific antibody levels measured as mean fluorescence intensity (MFImax). The study included 146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac9519017d61dd5e23b09cd65f3cf1f
http://europepmc.org/articles/PMC3672254
http://europepmc.org/articles/PMC3672254